Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ina Oehme

21PUBLICATIONS

99CO-AUTHORS

Molecular targetsGene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Liquid biopsiesHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|Dec 19, 2025

Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors.

Dina ElHarouni, Rosa Hernansaiz-Ballesteros, Heike Peterziel

|Aug 25, 2025

High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas.

Sonja Herter, Marta Emperador, Kyriaki Smyrilli

|Jun 26, 2025

Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor-adapted non-small cell lung cancer cell lines.

Tharsagini V Nanthaprakash, Campbell W Gourlay, Ina Oehme

|Jun 16, 2025

Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomas.

Roland Imle, Daniel Blösel, Felix K F Kommoss

|Apr 29, 2025

The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells.

Andreas O Mieland, Giuseppe Petrosino, Mario Dejung

|Jan 03, 2025

Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell lines.

Merve Kasan, Florian H Geyer, Jana Siebenlist

Pageof 4

Frequent Collaborators

5 joint publications

Till Milde

4 joint publications

Wolfgang Sippl

4 joint publications

Stefan M Pfister

4 joint publications

Cornelis M van Tilburg

4 joint publications

Heike Peterziel

3 joint publications

Johannes Ridinger

3 joint publications

Corey J Herbst-Gervasoni

3 joint publications

Manfred Jung

3 joint publications

Aubry K Miller

3 joint publications

Romain Sigaud

Frequent Collaborators

5 joint publications

Till Milde

4 joint publications

Wolfgang Sippl

4 joint publications

Stefan M Pfister

4 joint publications

Cornelis M van Tilburg

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on : Jul 12, 2022

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on : Jul 12, 2022

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos